Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018.

Bluemel B, Goelz H, Goldmann B, Grüger J, Hamel H, Loley K, Ludolph T, Meyer J, Miehlke S, Mohr A, Tüffers K, Usadel H, Wagner S, Wenzel H, Wiemer L, Vorreiter J, Eisele B, Hofreuter D, Glocker EO.

Clin Microbiol Infect. 2019 Jun 15. pii: S1198-743X(19)30314-3. doi: 10.1016/j.cmi.2019.06.007. [Epub ahead of print]

PMID:
31212078
2.

Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing.

Blümel B, Goelz H, Kist M, Glocker EO.

Helicobacter. 2018 Aug;23(4):e12494. doi: 10.1111/hel.12494. Epub 2018 Jun 6.

PMID:
29873430
3.

Hematopoietic Stem Cell Transplantation From Unrelated Donors in 2 Cases of Interleukin-10 Receptor Deficiency: Is Surgery Not a Requirement?

Kocacik Uygun DF, Uygun V, Daloğlu H, Öztürkmen S, Karasu G, Reisli İ, Sayar E, Yüksekkaya HA, Glocker EO, Boztuğ K, Yeşilipek A.

J Pediatr Hematol Oncol. 2019 Jan;41(1):64-66. doi: 10.1097/MPH.0000000000001165.

PMID:
29683948
4.

Antimicrobial susceptibility testing of Arcobacter butzleri: development and application of a new protocol for broth microdilution.

Riesenberg A, Frömke C, Stingl K, Feßler AT, Gölz G, Glocker EO, Kreienbrock L, Klarmann D, Werckenthin C, Schwarz S.

J Antimicrob Chemother. 2017 Oct 1;72(10):2769-2774. doi: 10.1093/jac/dkx211.

PMID:
29091194
5.

Targeted Gene Panel Sequencing for Early-onset Inflammatory Bowel Disease and Chronic Diarrhea.

Petersen BS, August D, Abt R, Alddafari M, Atarod L, Baris S, Bhavsar H, Brinkert F, Buchta M, Bulashevska A, Chee R, Cordeiro AI, Dara N, Dückers G, Elmarsafy A, Frede N, Galal N, Gerner P, Glocker EO, Goldacker S, Hammermann J, Hasselblatt P, Havlicekova Z, Hübscher K, Jesenak M, Karaca NE, Karakoc-Aydiner E, Kharaghani MM, Kilic SS, Kiykim A, Klein C, Klemann C, Kobbe R, Kotlarz D, Laass MW, Leahy TR, Mesdaghi M, Mitton S, Neves JF, Öztürk B, Pereira LF, Rohr J, Restrepo JLR, Ruzaike G, Saleh N, Seneviratne S, Senol E, Speckmann C, Tegtmeyer D, Thankam P, van der Werff Ten Bosch J, von Bernuth H, Zeissig S, Zeissig Y, Franke A, Grimbacher B.

Inflamm Bowel Dis. 2017 Dec;23(12):2109-2120. doi: 10.1097/MIB.0000000000001235.

PMID:
28930861
6.

Efficacy of three-in-one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient population.

Miehlke S, Frederking D, Günther T, Glocker E, Eisele B, Andresen V, Schröder S, Morgner A.

Helicobacter. 2017 Dec;22(6). doi: 10.1111/hel.12429. Epub 2017 Aug 22.

PMID:
28833925
7.

Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies?

Pott MC, Frede N, Wanders J, Hammarström L, Glocker EO, Glocker C, Tahami F, Grimbacher B.

BMC Immunol. 2017 Jun 26;18(1):34. doi: 10.1186/s12865-017-0217-9.

8.

The Importance of Measuring IL10 Levels in Patients with Suspected IL10/IL10R Defects.

LaBarba S, Sahn B, Glocker E, Eisele B, Jongco A, Bonagura V.

J Clin Immunol. 2016 Nov;36(8):747-749. Epub 2016 Oct 3. No abstract available.

PMID:
27699570
9.

[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

Fischbach W, Malfertheiner P, Lynen Jansen P, Bolten W, Bornschein J, Buderus S, Glocker E, Hoffmann JC, Koletzko S, Labenz J, Mayerle J, Miehlke S, Mössner J, Peitz U, Prinz C, Selgrad M, Suerbaum S, Venerito M, Vieth M; Verantwortlich für die DGVS.

Z Gastroenterol. 2016 Apr;54(4):327-63. German. No abstract available. Erratum in: Z Gastroenterol. 2016 Apr;54(4):1.

10.

[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

Fischbach W, Malfertheiner P, Lynen Jansen P, Bolten W, Bornschein J, Buderus S, Glocker E, Hoffmann CJ, Koletzko S, Labenz J, Mayerle J, Miehlke S, Mössner J, Peitz U, Prinz C, Selgrad M, Suerbaum S, Venerito M, Vieth M; Verantwortlich für die DGVS.

Z Gastroenterol. 2016 Apr;54(4):1. doi: 10.1055/s-0035-1567086. Epub 2016 May 11. German.

11.

The Ineffectiveness of Tacrolimus in an Infant With a Mutation in the IL-10 Receptor.

Sayar E, Yucel A, Eisele B, Sayar EH, Glocker E, Yuksekkaya HA.

J Clin Gastroenterol. 2016 Apr;50(4):352-3. doi: 10.1097/MCG.0000000000000480. No abstract available.

PMID:
26828243
12.
13.

Outcome of second- and third-line Helicobacter pylori eradication therapies based on antimicrobial susceptibility testing.

Draeger S, Wüppenhorst N, Kist M, Glocker EO.

J Antimicrob Chemother. 2015 Nov;70(11):3141-5. doi: 10.1093/jac/dkv223. Epub 2015 Aug 5.

PMID:
26245638
14.

[What is new in treating Helicobacter pylori infection?].

Scherübl H, Fischbach W, Glocker E, Malfertheiner P.

Dtsch Med Wochenschr. 2015 Feb;140(4):277-80. doi: 10.1055/s-0041-100463. Epub 2015 Feb 19. Review. German.

PMID:
25704525
15.

Feasibility and quality development of biomaterials in the pretest studies of the German National Cohort.

Kühn A, Nieters A, Köttgen A, Goek ON, Michels K, Nöthlings U, Jacobs G, Meisinger C, Pessler F, Akmatov MF, Kühnisch J, Moebus S, Glocker E, Naus S, Keimling M, Leitzmann M, Linseisen J, Sarioglu H, von Toerne C, Hauck SM, Wallaschofski H, Wichmann HE, Illig T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Nov;57(11):1255-63. doi: 10.1007/s00103-014-2048-7.

PMID:
25293886
16.

Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in Germany.

Wüppenhorst N, Draeger S, Stüger HP, Hobmaier B, Vorreiter J, Kist M, Glocker EO; ResiNet Study Group.

J Antimicrob Chemother. 2014 Nov;69(11):3127-33. doi: 10.1093/jac/dku243. Epub 2014 Jul 4.

PMID:
24997315
17.

Helicobacter pylori protects oncogenically transformed cells from reactive oxygen species-mediated intercellular induction of apoptosis.

Bauer G, Bereswill S, Aichele P, Glocker E.

Carcinogenesis. 2014 Jul;35(7):1582-91. doi: 10.1093/carcin/bgu074. Epub 2014 Mar 24.

PMID:
24662971
18.

Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease.

Frede N, Glocker EO, Wanders J, Engelhardt KR, Kreisel W, Ruemmele FM, Grimbacher B.

BMC Immunol. 2014 Feb 28;15:10. doi: 10.1186/1471-2172-15-10.

19.

Antiadhesive properties of Abelmoschus esculentus (Okra) immature fruit extract against Helicobacter pylori adhesion.

Messing J, Thöle C, Niehues M, Shevtsova A, Glocker E, Borén T, Hensel A.

PLoS One. 2014 Jan 9;9(1):e84836. doi: 10.1371/journal.pone.0084836. eCollection 2014.

20.

Presence of virulence genes, adhesion and invasion of Arcobacter butzleri.

Karadas G, Sharbati S, Hänel I, Messelhäußer U, Glocker E, Alter T, Gölz G.

J Appl Microbiol. 2013 Aug;115(2):583-90. doi: 10.1111/jam.12245. Epub 2013 May 30.

21.

High secondary resistance to quinolones in German Helicobacter pylori clinical isolates.

Wueppenhorst N, Stueger HP, Kist M, Glocker EO.

J Antimicrob Chemother. 2013 Jul;68(7):1562-6. doi: 10.1093/jac/dkt061. Epub 2013 Mar 5.

PMID:
23463210
22.

Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation.

Engelhardt KR, Shah N, Faizura-Yeop I, Kocacik Uygun DF, Frede N, Muise AM, Shteyer E, Filiz S, Chee R, Elawad M, Hartmann B, Arkwright PD, Dvorak C, Klein C, Puck JM, Grimbacher B, Glocker EO.

J Allergy Clin Immunol. 2013 Mar;131(3):825-30. doi: 10.1016/j.jaci.2012.09.025. Epub 2012 Nov 14.

PMID:
23158016
23.

Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease.

Shah N, Kammermeier J, Elawad M, Glocker EO.

Curr Allergy Asthma Rep. 2012 Oct;12(5):373-9. doi: 10.1007/s11882-012-0286-z. Review.

PMID:
22890722
24.

Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?

McNulty CA, Lasseter G, Shaw I, Nichols T, D'Arcy S, Lawson AJ, Glocker E.

Aliment Pharmacol Ther. 2012 May;35(10):1221-30. doi: 10.1111/j.1365-2036.2012.05083.x. Epub 2012 Apr 2.

25.

IL-10 and IL-10 receptor defects in humans.

Glocker EO, Kotlarz D, Klein C, Shah N, Grimbacher B.

Ann N Y Acad Sci. 2011 Dec;1246:102-7. doi: 10.1111/j.1749-6632.2011.06339.x. Review.

PMID:
22236434
26.

Inflammatory bowel disease: is it a primary immunodeficiency?

Glocker E, Grimbacher B.

Cell Mol Life Sci. 2012 Jan;69(1):41-8. doi: 10.1007/s00018-011-0837-9. Epub 2011 Oct 14. Review.

PMID:
21997382
27.

Mucosal antifungal defence: IL-17 signalling takes centre stage.

Glocker EO, Grimbacher B.

Immunol Cell Biol. 2011 Nov;89(8):823-5. doi: 10.1038/icb.2011.39. Epub 2011 May 17. No abstract available.

PMID:
21577231
28.

Infant colitis--it's in the genes.

Glocker EO, Frede N, Perro M, Sebire N, Elawad M, Shah N, Grimbacher B.

Lancet. 2010 Oct 9;376(9748):1272. doi: 10.1016/S0140-6736(10)61008-2. No abstract available.

PMID:
20934598
29.

Chronic mucocutaneous candidiasis and congenital susceptibility to Candida.

Glocker E, Grimbacher B.

Curr Opin Allergy Clin Immunol. 2010 Dec;10(6):542-50. doi: 10.1097/ACI.0b013e32833fd74f. Review.

PMID:
20859203
30.

Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.

Woellner C, Gertz EM, Schäffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, Pietrucha B, Heropolitańska-Pliszka E, Yeganeh M, Moin M, Español T, Ehl S, Gennery AR, Abinun M, Breborowicz A, Niehues T, Kilic SS, Junker A, Turvey SE, Plebani A, Sánchez B, Garty BZ, Pignata C, Cancrini C, Litzman J, Sanal O, Baumann U, Bacchetta R, Hsu AP, Davis JN, Hammarström L, Davies EG, Eren E, Arkwright PD, Moilanen JS, Viemann D, Khan S, Maródi L, Cant AJ, Freeman AF, Puck JM, Holland SM, Grimbacher B.

J Allergy Clin Immunol. 2010 Feb;125(2):424-432.e8. doi: 10.1016/j.jaci.2009.10.059.

31.

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.

Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hätscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C.

N Engl J Med. 2009 Nov 19;361(21):2033-45. doi: 10.1056/NEJMoa0907206. Epub 2009 Nov 4.

32.

A homozygous CARD9 mutation in a family with susceptibility to fungal infections.

Glocker EO, Hennigs A, Nabavi M, Schäffer AA, Woellner C, Salzer U, Pfeifer D, Veelken H, Warnatz K, Tahami F, Jamal S, Manguiat A, Rezaei N, Amirzargar AA, Plebani A, Hannesschläger N, Gross O, Ruland J, Grimbacher B.

N Engl J Med. 2009 Oct 29;361(18):1727-35. doi: 10.1056/NEJMoa0810719.

33.

Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.

Wueppenhorst N, Stueger HP, Kist M, Glocker E.

J Antimicrob Chemother. 2009 Apr;63(4):648-53. doi: 10.1093/jac/dkp003. Epub 2009 Feb 3.

PMID:
19190100
34.

Developmental switch of intestinal antimicrobial peptide expression.

Ménard S, Förster V, Lotz M, Gütle D, Duerr CU, Gallo RL, Henriques-Normark B, Pütsep K, Andersson M, Glocker EO, Hornef MW.

J Exp Med. 2008 Jan 21;205(1):183-93. doi: 10.1084/jem.20071022. Epub 2008 Jan 7.

35.

Common variable immunodeficiency in children.

Glocker E, Ehl S, Grimbacher B.

Curr Opin Pediatr. 2007 Dec;19(6):685-92. Review.

PMID:
18025937
36.

Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany.

Glocker E, Bogdan C, Kist M.

J Antimicrob Chemother. 2007 May;59(5):874-9. Epub 2007 Mar 9.

PMID:
17350989
37.

A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14.

Bohn G, Allroth A, Brandes G, Thiel J, Glocker E, Schäffer AA, Rathinam C, Taub N, Teis D, Zeidler C, Dewey RA, Geffers R, Buer J, Huber LA, Welte K, Grimbacher B, Klein C.

Nat Med. 2007 Jan;13(1):38-45. Epub 2006 Dec 31.

PMID:
17195838
38.

Quinolone resistance in Helicobacter pylori isolates in Germany.

Glocker E, Stueger HP, Kist M.

Antimicrob Agents Chemother. 2007 Jan;51(1):346-9. Epub 2006 Oct 16.

39.

Emergence of a Helicobacter pylori isolate with reduced susceptibility to tetracycline in Germany.

Glocker E, Kist M.

J Antimicrob Chemother. 2006 Nov;58(5):1103-4. Epub 2006 Aug 18. No abstract available.

PMID:
16920745
40.

Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori.

Glocker E, Berning M, Gerrits MM, Kusters JG, Kist M.

Antimicrob Agents Chemother. 2005 Aug;49(8):3166-70.

41.

[Pathogenesis, diagnostics and treatment of Helicobacter pylori infection].

Kist M, Glocker E, Suerbaum S.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Jun;48(6):669-78. Review. German.

PMID:
15983844
43.

Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.

Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Dräger R, Eibel H, Fischer B, Schäffer AA, Mages HW, Kroczek RA, Peter HH.

Nat Immunol. 2003 Mar;4(3):261-8. Epub 2003 Feb 10.

PMID:
12577056
44.

Linkage of autosomal dominant common variable immunodeficiency to chromosome 5p and evidence for locus heterogeneity.

Braig DU, Schäffer AA, Glocker E, Salzer U, Warnatz K, Peter HH, Grimbacher B.

Hum Genet. 2003 Apr;112(4):369-78. Epub 2003 Feb 6.

PMID:
12574940
45.

Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation.

Glocker E, Lange C, Covacci A, Bereswill S, Kist M, Pahl HL.

Infect Immun. 1998 May;66(5):2346-8.

46.

A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B.

Münzenmaier A, Lange C, Glocker E, Covacci A, Moran A, Bereswill S, Baeuerle PA, Kist M, Pahl HL.

J Immunol. 1997 Dec 15;159(12):6140-7.

PMID:
9550415
47.

[Obesity, smoking and other risk factors in 357 cases of cerebrovascular disorders].

Glocker E, Hänsel D, Kornhuber HH.

Dtsch Med Wochenschr. 1977 Oct 7;102(40):1437. German. No abstract available.

PMID:
913273

Supplemental Content

Loading ...
Support Center